Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02481869 · ClinicalTrials.gov registry record · NA
Platelet Rich Plasma Injection in Pilon Fractures
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02481869 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 11 participants.
The verdict
NCT02481869, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Patients who sustain broken ankles have a very high risk of developing arthritis soon after injury (within 2 years). This arthritis can cause increased pain and a decrease level of function, especially if the injury occurs at an early age. During and shortly after ankle injury, there is an inflammatory chemical process that takes place in the ankle that can cause damage to the cartilage in the ankle joint. The investigators want to use what is called Platelet Rich Plasma (PRP), which is produced from a small amount of the patient's own blood, to inject into the injured ankle to see if they can decrease the inflammation that happens after the injury and to see if they can decrease arthritis.
Interventions
- BIOLOGICAL Arthrocentesis/PRP
- DRUG Arthrocentesis/Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02481869
The ClinicalTrials.gov registry entry for NCT02481869 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Arthrocentesis/PRP is the first listed.
NCT02481869 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02481869 about?
NCT02481869 is a clinical study titled "Platelet Rich Plasma Injection in Pilon Fractures". Patients who sustain broken ankles have a very high risk of developing arthritis soon after injury (within 2 years). This arthritis can cause increased pain and a decrease level of function, especially if the injury occurs at an early age. During and shortly after ankle injury, there is an inflammat...
What is the current status of trial NCT02481869?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2015-06. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02481869?
The interventions under investigation include: Arthrocentesis/PRP (BIOLOGICAL), Arthrocentesis/Saline (DRUG).
Who is sponsoring clinical trial NCT02481869?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.